Accueil › Annuaire des chercheurs › Ignacio Moraleda

Ignacio Moraleda

Affiliation : Universidad de Alcalá

• 11Publications (affiliation espagnole)
• 42Publications au total
• 1875Citations
• 26Indice h

ORCIDOpenAlex

Domaines de recherche

• Cholinesterase and Neurodegenerative Diseases
• Alzheimer's disease research and treatments
• Synthesis and biological activity
• Enzyme function and inhibition
• Neurological Disorders and Treatments

Publications (11)

• Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
  2021 · ChemistrySelect · cité 5 fois
• New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
  2019 · Journal of Medicinal Chemistry · cité 45 fois
• Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer’s disease therapy
  2019 · Bioorganic Chemistry · cité 38 fois
• Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
  2018 · Journal of Enzyme Inhibition and Medicinal Chemistry · cité 21 fois
• Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
  2018 · ChemistrySelect · cité 10 fois
• Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinetriones as Promising Agents for Alzheimer'S Disease Therapy
  2017 · Future Medicinal Chemistry · cité 11 fois
• Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease
  2016 · European Journal of Medicinal Chemistry · cité 51 fois
• Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
  2016 · European Journal of Medicinal Chemistry · cité 42 fois
• Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy
  2016 · Molecules · cité 28 fois
• Harmaline and hispidin from Peganum harmala and Inonotus hispidus with binding affinity to Candida rugosa lipase: In silico and in vitro studies
  2015 · Bioorganic Chemistry · cité 62 fois
• Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease
  2012 · European Journal of Medicinal Chemistry · cité 69 fois

Revues de publication

• European Journal of Medicinal Chemistry × 3
• ChemistrySelect × 2
• Bioorganic Chemistry × 2
• Journal of Medicinal Chemistry × 1
• Journal of Enzyme Inhibition and Medicinal Chemistry × 1
• Future Medicinal Chemistry × 1

Publications par année

• 20211
• 20192
• 20182
• 20171
• 20163
• 20151
• 20121

Collaborations

Établissements partenaires : Consejo Superior de Investigaciones Científicas · Instituto de Química Orgánica General · Instituto de Química Médica · Universidad Complutense de Madrid · Hospital Universitario de La Princesa

Co-auteurs

• Isabel Iriepa
• Jose Luis Marco
• Mourad Chioua
• María Jesús Oset‐Gasque
• Cristóbal de los Rı́os
• Concepción Pérez
• María Pilar González
• Cristina García‐Iriepa
• Alejandra Palomino‐Antolín
• Estefanía Serrano
• Nuria García-Font
• Marı́a Isabel Rodrı́guez-Franco

Données bibliographiques issues d’OpenAlex (base ouverte).